IRIS

Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis / Bonovas, S., Nikolopoulos, G.k., Piovani, D., Gonzalez-Lorenzo, M., Pantavou, K., Lytras, T., Peyrin-Biroulet, L., Danese, S.. - In: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. - ISSN 0306-5251. - 85:10(2019), pp. 2244-2254. [10.1111/bcp.14051]

Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis

Danese S
2019-01-01
2019
Inglese
Blackwell Publishing Ltd
85
10
2244
2254
11
2-s2.0-85070091888
WOS:000479107400001
31269287
Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis / Bonovas, S., Nikolopoulos, G.k., Piovani, D., Gonzalez-Lorenzo, M., Pantavou, K., Lytras, T., Peyrin-Biroulet, L., Danese, S.. - In: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. - ISSN 0306-5251. - 85:10(2019), pp. 2244-2254. [10.1111/bcp.14051]
none
8
info:eu-repo/semantics/article
262
Bonovas, S; Nikolopoulos, Gk; Piovani, D; Gonzalez-Lorenzo, M; Pantavou, K; Lytras, T; Peyrin-Biroulet, L; Danese, S
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119574
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 16
social impact